BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 4403402)

  • 21. A phagocytosis promoting factor of rat serum independent of the complement system.
    McLain S; Siegel J; Molnar J; Allen C; Sabet T
    J Reticuloendothel Soc; 1976 Mar; 19(3):127-38. PubMed ID: 1263186
    [No Abstract]   [Full Text] [Related]  

  • 22. [Opsonizing activity of the serum of gnotobiotic guinea pigs contaminated with individual representatives of intestinal microflora].
    Andreev VN; Podoprigora GI
    Biull Eksp Biol Med; 1977 Feb; 83(2):196-8. PubMed ID: 403978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsonic activity of guinea pig serum is reduced by in vivo administration of carcinogenic nitrosamines.
    Marom Z; Brade V; Colten HR
    J Immunol; 1978 Mar; 120(3):983-5. PubMed ID: 632598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on an extract from Haemophilus influenzae type a. II.--Phagocytic capacity of sera obtained from rabbits immunized by this bacterial extract (author's transl)].
    Raichvarg D; Brossard C; Agneray J
    Pathol Biol (Paris); 1980 May; 28(5):299-303. PubMed ID: 6992066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of chicken plasma and guinea pig serum in a quantitative microtiter method of determining microbial complement resistance.
    Wooley RE; Brown J; Spears KR; Nolan LK
    Avian Dis; 1991; 35(4):897-900. PubMed ID: 1786020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies on the opsonizing properties of blood serum, collostrum and milk in different species of animals in their ontogenetic development. I. Opsonizing properties of collostrum and milk of rabbits and sheep.
    Godzińska H; Podolska E; Slopek S
    Arch Immunol Ther Exp (Warsz); 1970; 18(3):298-304. PubMed ID: 5489283
    [No Abstract]   [Full Text] [Related]  

  • 29. [The bactericidal activity of leucocytes in various disease].
    Vildé JL
    Nouv Rev Fr Hematol; 1974; 14(2):301-8. PubMed ID: 4277287
    [No Abstract]   [Full Text] [Related]  

  • 30. [Methods of studying nonspecific body resistance used in hygiene].
    Golikov VIa; Taranenko LA
    Gig Sanit; 1982 Jul; (7):52-5. PubMed ID: 6751943
    [No Abstract]   [Full Text] [Related]  

  • 31. Participation of nonspecific factors in the destruction of type M 12 streptococcus in vitro. I. Nonspecific absorption of anti-M 12 bactericidal activity.
    Kahlich R; Procházka O
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):75-87. PubMed ID: 4985648
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking of phagocytosis of microorganisms in guinea pig serum by means of antiopsonin.
    Slopek S; Grzybek-Hryncewicz K; Ladosz J; Kubis K
    Arch Immunol Ther Exp (Warsz); 1965; 13(6):593-6. PubMed ID: 5325177
    [No Abstract]   [Full Text] [Related]  

  • 34. Opsonic antibodies of healthy human sera against some opportunistic pathogens.
    Arai T; Komatsu S; Ullah A
    Kitasato Arch Exp Med; 1983 Sep; 56(3):63-71. PubMed ID: 6431174
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phagocytosis in rickets].
    Kasal P; Ströder J
    Z Kinderheilkd; 1970; 108(2):149-55. PubMed ID: 4931635
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocytic function in hypogammaglobulinemia.
    Mickenberg ID; Root RK; Wolff SM
    J Clin Invest; 1970 Aug; 49(8):1528-38. PubMed ID: 4194088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of the autonomic nervous system on phagocytosis. IV. Changes caused by stimulation of the sympathetic system with cobefrin.
    Ladosz J
    Arch Immunol Ther Exp (Warsz); 1969; 17(1):18-26. PubMed ID: 5766889
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of the autonomic nervous system on phagocytosis. II. Changes caused by inhibition of the adrenergic system by means of dihydroergotamine.
    Ladosz J
    Arch Immunol Ther Exp (Warsz); 1968; 16(4):586-95. PubMed ID: 5710053
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complement, its role in phagocytosis phenomenon].
    Grzybek-Hryncewicz K
    Postepy Hig Med Dosw; 1967; 21(5):611-740. PubMed ID: 4863454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.